• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子放疗:用于计算时间积分活度系数的 NUKFIT 软件。

Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.

机构信息

Klinik für Nuklearmedizin, Universität Ulm, Ulm 89081, Germany.

出版信息

Med Phys. 2013 Oct;40(10):102504. doi: 10.1118/1.4820367.

DOI:10.1118/1.4820367
PMID:24089925
Abstract

PURPOSE

Calculation of the time-integrated activity coefficient (residence time) is a crucial step in dosimetry for molecular radiotherapy. However, available software is deficient in that it is either not tailored for the use in molecular radiotherapy and/or does not include all required estimation methods. The aim of this work was therefore the development and programming of an algorithm which allows for an objective and reproducible determination of the time-integrated activity coefficient and its standard error.

METHODS

The algorithm includes the selection of a set of fitting functions from predefined sums of exponentials and the choice of an error model for the used data. To estimate the values of the adjustable parameters an objective function, depending on the data, the parameters of the error model, the fitting function and (if required and available) Bayesian information, is minimized. To increase reproducibility and user-friendliness the starting values are automatically determined using a combination of curve stripping and random search. Visual inspection, the coefficient of determination, the standard error of the fitted parameters, and the correlation matrix are provided to evaluate the quality of the fit. The functions which are most supported by the data are determined using the corrected Akaike information criterion. The time-integrated activity coefficient is estimated by analytically integrating the fitted functions. Its standard error is determined assuming Gaussian error propagation. The software was implemented using MATLAB.

RESULTS

To validate the proper implementation of the objective function and the fit functions, the results of NUKFIT and SAAM numerical, a commercially available software tool, were compared. The automatic search for starting values was successfully tested for reproducibility. The quality criteria applied in conjunction with the Akaike information criterion allowed the selection of suitable functions. Function fit parameters and their standard error estimated by using SAAM numerical and NUKFIT showed differences of <1%. The differences for the time-integrated activity coefficients were also <1% (standard error between 0.4% and 3%). In general, the application of the software is user-friendly and the results are mathematically correct and reproducible. An application of NUKFIT is presented for three different clinical examples.

CONCLUSIONS

The software tool with its underlying methodology can be employed to objectively and reproducibly estimate the time integrated activity coefficient and its standard error for most time activity data in molecular radiotherapy.

摘要

目的

计算时间积分活度系数(停留时间)是分子放射治疗剂量学的关键步骤。然而,现有的软件存在缺陷,要么不适合分子放射治疗使用,要么不包括所有必需的估计方法。因此,本工作的目的是开发和编程一种算法,以客观和可重复的方式确定时间积分活度系数及其标准误差。

方法

该算法包括从预定义的指数和的和中选择一组拟合函数,并为所用数据选择误差模型。为了估计可调参数的值,依赖于数据、误差模型的参数、拟合函数(如果需要且可用)和贝叶斯信息的目标函数被最小化。为了提高可重复性和用户友好性,使用曲线剥离和随机搜索的组合自动确定起始值。视觉检查、决定系数、拟合参数的标准误差以及相关矩阵用于评估拟合质量。使用修正的 Akaike 信息准则确定最受数据支持的函数。通过分析积分拟合函数来估计时间积分活度系数。假设高斯误差传播,确定其标准误差。该软件使用 MATLAB 实现。

结果

为了验证目标函数和拟合函数的正确实现,比较了 NUKFIT 和 SAAM 数值的结果,后者是一种商业上可用的软件工具。自动搜索起始值的可重复性测试成功。与 Akaike 信息准则一起应用的质量标准允许选择合适的函数。使用 SAAM 数值和 NUKFIT 估计的函数拟合参数及其标准误差差异小于 1%。时间积分活度系数的差异也小于 1%(标准误差在 0.4%至 3%之间)。一般来说,该软件的应用用户友好,结果在数学上是正确且可重复的。呈现了 NUKFIT 在三个不同临床示例中的应用。

结论

该软件工具及其基础方法可用于客观和可重复地估计分子放射治疗中大多数时间活性数据的时间积分活度系数及其标准误差。

相似文献

1
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.分子放疗:用于计算时间积分活度系数的 NUKFIT 软件。
Med Phys. 2013 Oct;40(10):102504. doi: 10.1118/1.4820367.
2
The NUKDOS software for treatment planning in molecular radiotherapy.用于分子放射治疗治疗计划的NUKDOS软件。
Z Med Phys. 2015 Sep;25(3):264-74. doi: 10.1016/j.zemedi.2015.01.001. Epub 2015 Mar 17.
3
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.基于人群的模型选择,用于使用非线性混合效应建模准确估计时间积分活动。
Z Med Phys. 2024 Aug;34(3):419-427. doi: 10.1016/j.zemedi.2023.01.007. Epub 2023 Feb 20.
4
Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.剂量反应浏览器:一种用于探索和建模放射治疗剂量-体积结果关系的集成开源工具。
Phys Med Biol. 2006 Nov 21;51(22):5719-35. doi: 10.1088/0031-9155/51/22/001. Epub 2006 Oct 19.
5
A population-based method to determine the time-integrated activity in molecular radiotherapy.一种基于人群的方法来确定分子放射治疗中的时间积分活度。
EJNMMI Phys. 2021 Dec 14;8(1):82. doi: 10.1186/s40658-021-00427-x.
6
Phantom validation of coregistration of PET and CT for image-guided radiotherapy.用于图像引导放射治疗的PET与CT配准的体模验证
Med Phys. 2004 May;31(5):1083-92. doi: 10.1118/1.1688041.
7
INFOS: spectrum fitting software for NMR analysis.INFOS:用于核磁共振分析的光谱拟合软件。
J Biomol NMR. 2017 Feb;67(2):77-94. doi: 10.1007/s10858-016-0085-2. Epub 2017 Feb 3.
8
Erratum: "Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient" [Med. Phys. 40, 102504 (2013)].
Med Phys. 2014 Mar;41(3). doi: 10.1118/1.4865176.
9
Model selection for time-activity curves: the corrected Akaike information criterion and the F-test.模型选择的时间-活性曲线:校正的赤池信息量准则和 F 检验。
Z Med Phys. 2009;19(3):200-6. doi: 10.1016/j.zemedi.2009.05.003.
10
CERR: a computational environment for radiotherapy research.CERR:一种用于放射治疗研究的计算环境。
Med Phys. 2003 May;30(5):979-85. doi: 10.1118/1.1568978.

引用本文的文献

1
Non-linear mixed-effects modelling and population-based model selection for I kinetics in benign thyroid disease.良性甲状腺疾病中碘动力学的非线性混合效应建模与基于群体的模型选择
EJNMMI Phys. 2025 Apr 8;12(1):37. doi: 10.1186/s40658-025-00735-6.
2
MIRD Pamphlet No. 30: MIRDfit-A Tool for Fitting of Biodistribution Time-Activity Data for Internal Dosimetry.MIRD 手册第 30 号:MIRDfit——用于拟合内部剂量学生物分布时间-活性数据的工具。
J Nucl Med. 2024 Nov 1;65(11):1808-1814. doi: 10.2967/jnumed.124.268011.
3
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [Lu]Lu-PSMA-I&T Therapy.
参考多时间点剂量测定方案对[镥]镥-PSMA-I&T治疗单次时间点剂量测定有效性的影响。
J Nucl Med. 2024 Aug 1;65(8):1272-1278. doi: 10.2967/jnumed.123.266871.
4
Biodistribution and radiation dosimetry of [Tc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer.[锝]Tc-N4-BTG在前列腺癌生化复发患者中的生物分布及辐射剂量测定
EJNMMI Res. 2024 Apr 26;14(1):42. doi: 10.1186/s13550-024-01105-6.
5
Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.使用贝叶斯拟合方法对单时间点剂量测定中时间积分活度系数的不确定性分析
Nucl Med Mol Imaging. 2024 May;58(3):120-128. doi: 10.1007/s13139-024-00851-8. Epub 2024 Feb 23.
6
Fit of biokinetic data in molecular radiotherapy: a machine learning approach.分子放射治疗中生物动力学数据的拟合:一种机器学习方法。
EJNMMI Phys. 2024 Feb 22;11(1):19. doi: 10.1186/s40658-024-00623-5.
7
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.EANM 指导文件:用于首次人体研究和早期临床试验的剂量学。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1268-1286. doi: 10.1007/s00259-024-06640-x. Epub 2024 Feb 17.
8
MIB Guides: Preclinical Radiopharmaceutical Dosimetry.MIB 指南:临床前放射性药物剂量学。
Mol Imaging Biol. 2024 Feb;26(1):17-28. doi: 10.1007/s11307-023-01868-9. Epub 2023 Nov 14.
9
Tandem Isotope Therapy with Ac- and Lu-PSMA-617 in a Murine Model of Prostate Cancer.锕-225 和镥-177 标记 PSMA-617 双同位素治疗前列腺癌的小鼠模型研究。
J Nucl Med. 2023 Nov;64(11):1772-1778. doi: 10.2967/jnumed.123.265433. Epub 2023 Oct 5.
10
[Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience.[^99m^Tc]Tc-戊曲肽:研发、广泛的临床前评估及首个人体经验。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3937-3948. doi: 10.1007/s00259-023-06395-x. Epub 2023 Aug 19.